Share
Salveen Richter, Goldman Sachs lead U.S. biotech analyst, joins ‘Squawk on the Street’ to discuss Amgen’s mid-stage trial results for its experimental obesity drug, why she remains bullish on the company, where to invest in GLP-1 stocks, and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Byron Deeter, Bessemer Venture Partners partner, joins ‘Closing Bell Overtime’ to talk Snowflake’s best trading day ever. 03:44 Thu, Nov 21 20245:03 PM EST Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fran Horowitz, Abercrombie & Fitch Co. CEO, joins ‘Money Movers’ to discuss the company’s q3 earnings, weather impact on retail sector and tariffs. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mad Money with Jim Cramer ‘Mad Money’ host Jim Cramer looks at recent movements in the mega cap stocks and what’s behind them. 02:16 3 hours ago Jim Cramer Source link
CNBC brings you fast, accurate, and actionable business news and market updates. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Street Signs Asia Dominic Schnider of UBS Global Wealth Management says some of President-elect Donald Trump’s policies might be “counterproductive.” 02:37 26 minutes ago Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC’s Deirdre Bosa joins ‘Money Movers’ to discuss Amazon announcing it would invest an additional $4 billion in Anthropic, the artificial intelligence startup founded by ex-OpenAI research executives. Source link